| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Ro 3306 |
|---|
| Description | ATP-competitive cyclin-dependent kinase 1 (cdk1) inhibitor (Ki values range from 35 to 240 nM depending on cdk1 binding partner). Also reported to inhibit other cdks (Ki values are 0.89-1.32, 0.03 and >2 μM for cdk2, cdk3 and cdk4, respectively). Induces G2/M phase cell cycle arrest and apoptosis. Downregulates the expression of antiapoptotic proteins such as Bcl-2 and survivin and enhances downstream p53 signaling in acute myeloid leukemia (AML). Purity 98%. MW (observed): 351.45 |
|---|
| Size | 10 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 5-(6-Quinolinylmethylene)-2-[(2-thienylmethyl)amino]-4(5H)-thiazolone |
|---|
| Gene, Accession, CAS # | CAS: 872573-93-8 |
|---|
| Catalog # | 4181/10 |
|---|
| Price | |
|---|
| Order / More Info | Ro 3306 from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | PubMed: 23478441, 24740004, 25602147, 26293378, 26468278, 28607478 |
|---|
| 產(chǎn)品資料 |
|
|